vorinostat has been researched along with Anemia, Fanconi in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belo, H | 1 |
| Silva, G | 1 |
| Cardoso, BA | 1 |
| Porto, B | 1 |
| Minguillon, J | 1 |
| Barbot, J | 1 |
| Coutinho, J | 1 |
| Casado, JA | 1 |
| Benedito, M | 1 |
| Saturnino, H | 1 |
| Costa, E | 1 |
| Bueren, JA | 1 |
| Surralles, J | 1 |
| Almeida, A | 1 |
1 other study available for vorinostat and Anemia, Fanconi
| Article | Year |
|---|---|
Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.
Topics: Adolescent; Adult; Child; Child, Preschool; Chromatin; Chromosomal Instability; Computational Biolog | 2015 |